Improvement of Health-Related Quality of Life in Children with Inflammatory Bowel Disease Receiving Routine Intravenous Iron Supplementation
Authors:
- Istvan DankoIDIstvan Danko
- Marcy WeidkampMWMarcy Weidkamp
- Jens C. EickhoffJEJens C. Eickhoff
- 1 January 2019
- journal article
- Published by The Pediatric Pharmacy Association in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 24 (6) , 517-527
Abstract
OBJECTIVES Iron deficiency anemia (IDA) is very common in children with inflammatory bowel disease (IBD). While health-related quality of life (HRQL) is a key outcome measure, no long-term studies have evaluated the effect of correction of IDA on HRQL in children with IBD. Our goal was to prospectively study changes in HRQL in iron-deficient children with IBD receiving routine iron supplementation with periodic intravenous iron sucrose (IVIS). METHODS Thirty-eight children with IBD treated with infliximab participated. Hematology and inflammatory markers were assessed before each infliximab treatment. Iron-deficient patients (transferrin saturation below 20% and/or ferritin below 30 ng/mL or 100 ng/mL with normal or elevated C-reactive protein, respectively) received IVIS after each infliximab infusion until iron indices stayed normal for two consecutive measurements. HRQL was assessed with Pediatric Quality of Life Inventory every 4 months. Correlation between changes in mean hemoglobin levels and HRQL scores was analyzed prospectively in 3-month periods over a period exceeding 3 years. RESULTS At enrollment, 27 patients had already been established on infliximab; 11 had not started or completed induction. Mean iron indices and hemoglobin normalized after 3 and 6 month of starting IVIS, respectively. Multiple HRQL parameters significantly improved, regardless of the duration of infliximab treatment at the time of enrollment. There was a statistically significant positive correlation between correction of anemia and improvement in parent-reported emotional and physical HRQL scores. CONCLUSIONS Periodic IVIS resulted in long-term correction of IDA in children with IBD. Correction of IDA contributed to some improvements in HRQL.Keywords
This publication has 34 references indexed in Scilit:
- Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of lifeScandinavian Journal of Gastroenterology, 2013
- Psychosocial Issues in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2013
- Diagnosis and management of iron deficiency anemia in patients with IBDNature Reviews Gastroenterology & Hepatology, 2010
- Pathogenesis and treatment of anemia in inflammatory bowel diseaseHaematologica, 2010
- Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre studyScandinavian Journal of Gastroenterology, 2009
- Evidence-based Assessment of Health-related Quality of Life and Functional Impairment in Pediatric PsychologyJournal of Pediatric Psychology, 2008
- Measuring Quality of Life in Pediatric Patients With Inflammatory Bowel Disease: Psychometric and Clinical CharacteristicsJournal of Pediatric Gastroenterology and Nutrition, 2008
- Systematic review: managing anaemia in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2006
- Iron Deficiency and Cognitive FunctionAnnual Review of Nutrition, 1993
- Development and Validation of a Pediatric Crohnʼs Disease Activity IndexJournal of Pediatric Gastroenterology and Nutrition, 1991